Source: Healio News
Post-induction of a mass spectrometry tool called Mass-Fix predicted survival outcomes among patients with multiple myeloma participating on the STAMINA trial.
Mass-Fix, mass spectrometry of blood by MALDI, is an inexpensive, sensitive and specific means of non-invasively uncovering monoclonal immunoglobulins, according to the abstract presented at the virtual ASCO Annual Meeting.
“There are many advantages,” Angela Dispenzieri, MD, from the division of hematology at Mayo Clinic, said in her presentation. “It’s more sensitive than immunofixation. It can differentiate